Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Enterprise Value: 2020-2025

Historic Enterprise Value for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $4.3 billion.

  • Cellebrite DI's Enterprise Value rose 26.30% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year increase of 25.25%. This contributed to the annual value of $4.3 billion for FY2024, which is 204.88% up from last year.
  • Cellebrite DI's Enterprise Value amounted to $4.3 billion in Q3 2025, which was up 15.42% from $3.7 billion recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Enterprise Value registered a high of $4.6 billion during Q1 2025, and its lowest value of $523.3 million during Q2 2021.
  • In the last 3 years, Cellebrite DI's Enterprise Value had a median value of $2.4 billion in 2024 and averaged $2.7 billion.
  • Per our database at Business Quant, Cellebrite DI's Enterprise Value plummeted by 60.67% in 2022 and then soared by 204.88% in 2024.
  • Cellebrite DI's Enterprise Value (Quarterly) stood at $1.3 billion in 2021, then plummeted by 49.18% to $660.1 million in 2022, then soared by 111.29% to $1.4 billion in 2023, then spiked by 204.88% to $4.3 billion in 2024, then climbed by 26.30% to $4.3 billion in 2025.
  • Its last three reported values are $4.3 billion in Q3 2025, $3.7 billion for Q2 2025, and $4.6 billion during Q1 2025.